Smarter Signal Management: AI, big data, and predictive analytics

What if you could predict potential safety issues before clinical development begins? Innovative new signal detection and management approaches have been developed to help clinical trial sponsors, manufacturers, and CROs combat safety-related challenges and provide insight to be used to predict potential safety issues even before clinical development begins. Applying those learnings to their choice of initial research candidates can ultimately mean safer medicines for patients.

Articles in this issue

---

Smarter Signal Management: AI, big data, and predictive analytics

Related Content

Advertisement

August 1st 2025

Understanding Access Barriers to Physician-Administered Therapies for Rheumatoid Arthritis

This whitepaper presents a structured analysis of prior authorization outcomes for RA treatments requiring medical benefit coverage. It examines real-world access barriers from the perspective of payer decision patterns, documentation requirements, site of care, and plan type. Unlike claims-based studies or survey-based research, this analysis draws from actual prior authorization cases, providing a direct window into the real-world challenges faced by prescribers and patients alike.

August 1st 2025

Breaking Through Prior Authorization (PA) Barriers for a Leading Neurology Brand

Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.

August 1st 2025

Strategic Interventions Drive Down Therapeutic Discontinuation Rate

Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.

August 1st 2025

Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program

ConnectiveRx

August 1st 2025

Success Guide – Marketing’s Final Mile

ACTO

August 1st 2025

Success Guide – First Contact to Field Excellence in Pharma

ACTO

Related Content

Advertisement

August 1st 2025

Understanding Access Barriers to Physician-Administered Therapies for Rheumatoid Arthritis

This whitepaper presents a structured analysis of prior authorization outcomes for RA treatments requiring medical benefit coverage. It examines real-world access barriers from the perspective of payer decision patterns, documentation requirements, site of care, and plan type. Unlike claims-based studies or survey-based research, this analysis draws from actual prior authorization cases, providing a direct window into the real-world challenges faced by prescribers and patients alike.

August 1st 2025

Breaking Through Prior Authorization (PA) Barriers for a Leading Neurology Brand

Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.

August 1st 2025

Strategic Interventions Drive Down Therapeutic Discontinuation Rate

Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.

August 1st 2025

Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program

ConnectiveRx

August 1st 2025

Success Guide – Marketing’s Final Mile

ACTO

August 1st 2025

Success Guide – First Contact to Field Excellence in Pharma

ACTO